Company Name:Editas Medicine, Inc.
CEO: Cynthia L. Collins

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.


Key numbers

Market Capitalization:1920477780
Shares Outstanding: 54996500
Float: 54202791
Next Earning Date:2020-11-10
TTm EPS: -2.5163
TTm Dividend Rate:
200 days moving average:27.03
50 days moving average: 31.31
One day percent Change: 0.06



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,